Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Neijt

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Toxicology and Applied Pharmacology|June 15, 1987
Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in ratsP De Koning, J P Neijt, F G Jennekens, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 21, 1987
[Treatment of colonic carcinoma with cytostatic agents]G H Blijham, J P Neijt, C H Veenhof, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Phase II study of gemcitabine in ovarian cancerG von Minckwitz, T Bauknecht, C M Visseren-Grul, et al.
Journal of the National Cancer Institute|October 19, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patientsB Lund, O P Hansen, K Theilade, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 28, 1987
[Cytostatic agents in the treatment of stomach carcinoma]C H Veenhof, B G Taal, J P Neijt, et al.
Anti-Cancer Drugs|December 1, 1995
Phase II study of gemcitabine in previously platinum-treated ovarian cancer patientsB Lund, O P Hansen, J P Neijt, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 15, 1989
The bioavailability of three altretamine formulationsE A Runhaar, J P Neijt, J J Holthuis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1986
Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot studyA C Dullemond-Westland, J P Neijt, J W Nortier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphateO R Leeuwenkamp, J P Neijt, W J van der Vijgh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDPO R Leeuwenkamp, W J van der Vijgh, J P Neijt, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Toxicology and Applied Pharmacology|June 15, 1987
Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in ratsP De Koning, J P Neijt, F G Jennekens, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 21, 1987
[Treatment of colonic carcinoma with cytostatic agents]G H Blijham, J P Neijt, C H Veenhof, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Phase II study of gemcitabine in ovarian cancerG von Minckwitz, T Bauknecht, C M Visseren-Grul, et al.
Journal of the National Cancer Institute|October 19, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patientsB Lund, O P Hansen, K Theilade, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 28, 1987
[Cytostatic agents in the treatment of stomach carcinoma]C H Veenhof, B G Taal, J P Neijt, et al.
Anti-Cancer Drugs|December 1, 1995
Phase II study of gemcitabine in previously platinum-treated ovarian cancer patientsB Lund, O P Hansen, J P Neijt, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 15, 1989
The bioavailability of three altretamine formulationsE A Runhaar, J P Neijt, J J Holthuis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1986
Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot studyA C Dullemond-Westland, J P Neijt, J W Nortier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphateO R Leeuwenkamp, J P Neijt, W J van der Vijgh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDPO R Leeuwenkamp, W J van der Vijgh, J P Neijt, et al.
Pageof 10